Shopping Cart 0
Cart Subtotal
USD 0

MallInckrodt Plc (MNK) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Mallinckrodt Plc (Mallinckrodt) is develops, produces, commercializes, and distributes specialty pharmaceutical therapies and products. The company offers both branded and specialty generics for autoimmune and rare diseases in the specialty therapeutic areas of rheumatology, nephrology, neurology, pulmonology and ophthalmology. It also offers analgesics and gastrointestinal products and immunotherapy and neonatal respiratory critical care therapies; active pharmaceutical ingredients (APIs) and external manufacturing services. The company sells its products either directly or through distributors to retail pharmacies, institutions and various end users. It has subsidiaries in Prince Edward Island, Ireland, Bermuda, Germany, Australia, Canada, Maryland, Delaware, Massachusetts, the UK, California, Netherlands, Alberta, Switzerland, and Luxembourg. Mallinckrodt is headquartered in Surrey, the UK.

MallInckrodt Plc (MNK)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

MallInckrodt Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

MallInckrodt Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

MallInckrodt Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

MallInckrodt Plc, Medical Equipment, Deal Details 11

Private Equity 11

Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 11

Partnerships 12

Mallinckrodt Enters into Licensing Agreement with NeuroproteXeon 12

Bellerophon Therapeutics Extends Licensing Agreement With INO Therapeutics 13

IBA Molecular Forms Joint Venture with Mallinckrodt 14

Terumo BCT Extends Distribution Agreement With Therakos 15

Terumo BCT Expands Agreement with Mallinckrodt 16

Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 17

Mallinckrodt Enters Into Co-Promotion Agreement With China Resources For Optiray 18

Ziehm Imaging Enters Into Agreement With Mallinckrodt For Vascular Applications 19

Debt Offering 20

Mallinckrodt to Raise up to USD1.2 Billion in Private Placement of Notes 20

Asset Transactions 21

Baxter International Acquires Two Hemostat and Sealant Products from Mallinckrodt 21

IBA Molecular Acquires Nuclear Imaging Business from Mallinckrodt 22

Guerbet Acquires Contrast Media and Delivery Systems Business from Mallinckrodt for USD270 Million 23

MediBeacon Acquires Portfolio Of Optical Diagnostic Agent Development Assets From Mallinckrod 24

Acquisition 25

Mallinckrodt Acquires Stratatech 25

Mallinckrodt Pharma Acquires Therakos from Gores Group 26

Mallinckrodt Acquires Ikaria for up to USD2.3 Billion 28

MallInckrodt Plc-Key Competitors 30

MallInckrodt Plc-Key Employees 31

MallInckrodt Plc-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 36

Strategy And Business Planning 36

Oct 16, 2017: Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces USD 100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students 36

Financial Announcements 37

Aug 07, 2018: Mallinckrodt reports second quarter 2018 results and raises guidance for 2018 37

May 08, 2018: Mallinckrodt Reports First Quarter 2018 Results 39

Feb 27, 2018: Mallinckrodt Reports Fourth Quarter and Fiscal 2017 Results, Announces 2018 Guidance and Sets 2018 Strategic Priorities 41

Nov 07, 2017: Mallinckrodt Reports Earnings Results for Third Quarter of Fiscal 2017 43

Aug 08, 2017: Mallinckrodt Reports Earnings Results for Second Quarter of Fiscal 2017 45

May 08, 2017: Mallinckrodt Reports Earnings Results for First Quarter of Fiscal 2017 47

Feb 07, 2017: Mallinckrodt Reports Transition Period Results and Announces 2017 Guidance 49

Corporate Communications 51

Oct 01, 2018: Mallinckrodt responds to CBS' 60 minutes segment 51

Jun 21, 2018: Mallinckrodt Launches Scientific Advisory Council 52

Apr 04, 2018: Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018 53

Apr 04, 2018: Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors 54

Feb 21, 2018: Mallinckrodt Earns Somerset County Planning Board Land Development Honor 55

Feb 01, 2018: Mallinckrodt Names Mark Casey As General Counsel 56

Other Significant Developments 57

Oct 04, 2017: Mallinckrodt Discusses Pipeline Transformation, Company Outlook at Investor Briefing 57

Jul 11, 2017: Mallinckrodt Finalizes Previously Announced Agreement with DEA and USAOs 58

Jun 06, 2017: Mallinckrodt Updates Facts Refuting Short-Seller Claims 59

Apr 03, 2017: Mallinckrodt Statement on DEA and USAOs Agreement in Principle 61

Appendix 62

Methodology 62

About GlobalData 62

Contact Us 62

Disclaimer 62


List Of Figure

List of Figures

MallInckrodt Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

MallInckrodt Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

MallInckrodt Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

MallInckrodt Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

MallInckrodt Plc, Medical Equipment, Key Facts, 2017 2

MallInckrodt Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

MallInckrodt Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

MallInckrodt Plc, Deals By Market, 2012 to YTD 2018 9

MallInckrodt Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 11

Mallinckrodt Enters into Licensing Agreement with NeuroproteXeon 12

Bellerophon Therapeutics Extends Licensing Agreement With INO Therapeutics 13

IBA Molecular Forms Joint Venture with Mallinckrodt 14

Terumo BCT Extends Distribution Agreement With Therakos 15

Terumo BCT Expands Agreement with Mallinckrodt 16

Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 17

Mallinckrodt Enters Into Co-Promotion Agreement With China Resources For Optiray 18

Ziehm Imaging Enters Into Agreement With Mallinckrodt For Vascular Applications 19

Mallinckrodt to Raise up to USD1.2 Billion in Private Placement of Notes 20

Baxter International Acquires Two Hemostat and Sealant Products from Mallinckrodt 21

IBA Molecular Acquires Nuclear Imaging Business from Mallinckrodt 22

Guerbet Acquires Contrast Media and Delivery Systems Business from Mallinckrodt for USD270 Million 23

MediBeacon Acquires Portfolio Of Optical Diagnostic Agent Development Assets From Mallinckrod 24

Mallinckrodt Acquires Stratatech 25

Mallinckrodt Pharma Acquires Therakos from Gores Group 26

Mallinckrodt Acquires Ikaria for up to USD2.3 Billion 28

MallInckrodt Plc, Key Competitors 30

MallInckrodt Plc, Key Employees 31

MallInckrodt Plc, Other Locations 32

MallInckrodt Plc, Subsidiaries 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

MallInckrodt Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.